Exclusion Criteria
Estrogen- and progesterone-receptor status negative or unknown
boolean
Completion of adjuvant tamoxifen therapy more than 6 months prior to study start
boolean
Inflammatory breast cancer
boolean
Current/active dental problems including infection of the teeth or jawbone, dental or fixture trauma, or a current or prior diagnosis of osteonecrosis of the jaw, of exposed bone in the mouth, or of slow healing after dental procedures
boolean
Recent (within 6 weeks) or planned dental or jaw surgery
boolean
History of diseases with influence on bone metabolism such as Paget's disease and primary overactive parathyroid
boolean
Prior or concomitant therapies: chemotherapy within the last 12 months, intravenous or oral bisphosphonates, systemic corticosteroids, anabolic steroids or growth hormones, Tibolone, parathyroid hormone, systemic sodium fluoride or any drugs known to affect the skeleton (such as calcitonin, mithramycin, or gallium nitrate)
boolean
Patients with previous or concomitant cancers (not breast cancer) within the past 5 years EXCEPT adequately treated basal or squamous cell skin cancers or in situ cancer of the cervix. Patients with previous other cancer(s) must have been disease-free for at least 5 years.
boolean
Patients currently receiving oral bisphosphonates must discontinue these at least 3 weeks prior to study start.
boolean